WDR45B
protein-codingWD repeat domain 45B, the group of WD repeat domain containing|WIPI family
Gene summary
This gene encodes a member of the WIPI or SVP1 family of WD40 repeat-containing proteins. The protein contains seven WD40 repeats that are thought to fold into a beta-propeller structure that mediates protein-protein interactions, and a conserved motif for interaction with phospholipids. The human genome contains several pseudogenes of this gene. [provided by RefSeq, Jul 2008]
- WDR45L
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~34.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0060704
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0060704
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0060704
Submitter: Baylor College of Medicine Research Center
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may potentially be beneficial related to manifestations such as renal issues; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to WDR45B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_019613.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 11 | 1 | 13 | ||
| missense | 32 | 2 | 34 | |||
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 1 | 2 | 38 | 13 | 1 | 55 |
Highest pathogenic variant AF is 0.0000037177347
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_062559.2 | 10 | MANE Select | |
| Ensembl | ENSP00000376139.4 | 10 | MANE Select | |
| Ensembl | ENSP00000461355.1 | 4 | Standard | |
| Ensembl | ENSP00000461488.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Macroautophagy
- Cellular responses to external stimuli
Biological Process
- autophagosome assembly
- autophagy of mitochondrion
- protein lipidation
- cellular response to starvation
- protein localization to phagophore assembly site
Molecular Function
- protein binding
- phosphatidylinositol-3-phosphate binding
- TSC1-TSC2 complex binding
- phosphatidylinositol-3,5-bisphosphate binding
Cellular Component
- phagophore assembly site
- lysosome
- cytosol
- extrinsic component of membrane
- phagophore assembly site membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000392325
- Coding exons
- 10
- Length
- 33992
- Individuals with no LoFs
- 125735
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 13
- Defined
- 125748
- p
- 0.0000517
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.01 | 150 | 189 | 0.793 | 0.0000112 | 2268 |
| Missense (PolyPhen) | 18 | 39.426 | 0.45655 | 471 | ||
| Synonymous | -0.863 | 88 | 78.3 | 1.12 | 0.00000558 | 646 |
| Loss of Function | 2.99 | 5 | 19.1 | 0.262 | 0.00000110 | 225 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00032 | 0.00032 | rare |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.99
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |